OTCMKTS:KAYS

Kaya Q2 2025 Earnings Results & Report

Kaya logo
$0.0013 0.00 (0.00%)
As of 11/18/2026 12:27 PM Eastern

Kaya reported Q2 2025 earnings on August 27, 2025. The company reported EPS of -$0.06, while revenue was $10 thousand.

Earnings Announcement Details

Quarter
Q2 2025
Report Date
Time
After Market Closes

Kaya EPS Results

Actual EPS
-$0.06
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Kaya Revenue Results

Actual Revenue
$10 thousand
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Kaya Q2 2025 Earnings FAQ

Kaya (OTCMKTS:KAYS) reported earnings of -$0.06 per share for Q2 2025. The report was announced on Wednesday, August 27, 2025.

Kaya reported revenue of $10 thousand for Q2 2025.

Kaya Earnings Headlines

KAYS Kaya Holdings, Inc.
What the hell is going on?
Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway. The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December. Watch Porter Stansberry's full broadcast to see which companies could be affected.tc pixel
Kaya Holdings Delays Annual 10-K Filing
Kaya Holdings Delays Filing of Annual Report
See More Kaya Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Kaya? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Kaya and other key companies, straight to your email.

About Kaya

Kaya (OTCMKTS:KAYS) is a cannabis company focused on Jamaica’s regulated medical cannabis market. Through its Jamaican operations, the company has pursued a vertically integrated business spanning cannabis cultivation, processing and retail sales.

Its Kaya Herb House brand serves consumers through medical cannabis dispensaries, while its cultivation and processing activities support the development of cannabis products for the Jamaican market. The company’s operations have centered on Jamaica, where it has operated since the country began establishing a regulated cannabis industry.

View Kaya Profile